Baxter PE Ratio 2006-2018 | BAX

Current and historical p/e ratio for Baxter (BAX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Baxter PE ratio as of April 24, 2019 is 25.01.
Baxter PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-04-25 76.25 25.50
2018-12-31 65.82 $2.99 22.01
2018-09-30 76.88 $2.21 34.79
2018-06-30 73.45 $1.66 44.25
2018-03-31 64.52 $1.51 42.73
2017-12-31 63.97 $1.29 49.59
2017-09-30 61.95 $1.86 33.31
2017-06-30 59.61 $1.65 36.13
2017-03-31 50.93 $3.36 15.16
2016-12-31 43.43 $8.99 4.83
2016-09-30 46.49 $8.92 5.21
2016-06-30 44.04 $8.68 5.07
2016-03-31 39.89 $7.09 5.63
2015-12-31 36.94 $1.75 21.11
2015-09-30 31.71 $3.12 10.16
2015-06-30 36.38 $3.98 9.14
2015-03-31 35.37 $4.33 8.17
2014-12-31 37.55 $4.56 8.23
2014-09-30 36.51 $3.41 10.71
2014-06-30 36.53 $3.54 10.32
2014-03-31 36.91 $3.66 10.09
2013-12-31 34.64 $3.65 9.49
2013-09-30 32.48 $3.95 8.22
2013-06-30 34.01 $4.02 8.46
2013-03-31 35.41 $4.14 8.55
2012-12-31 32.29 $4.18 7.72
2012-09-30 28.99 $4.11 7.05
2012-06-30 25.37 $4.06 6.25
2012-03-31 28.35 $3.94 7.19
2011-12-31 23.33 $3.88 6.01
2011-09-30 26.29 $3.78 6.96
2011-06-30 27.80 $3.78 7.35
2011-03-31 24.91 $3.61 6.90
2010-12-31 23.31 $3.49 6.68
2010-09-30 21.84 $3.71 5.89
2010-06-30 18.48 $3.57 5.18
2010-03-31 26.27 $3.63 7.24
2009-12-31 26.36 $3.60 7.32
2009-09-30 25.48 $3.57 7.14
2009-06-30 23.56 $3.44 6.85
2009-03-31 22.66 $3.33 6.80
2008-12-31 23.59 $3.17 7.44
2008-09-30 28.74 $3.00 9.58
2008-06-30 27.91 $2.87 9.73
2008-03-31 25.15 $2.67 9.42
2007-12-31 25.16 $2.61 9.64
2007-09-30 24.30 $2.53 9.61
2007-06-30 24.25 $2.49 9.74
2007-03-31 22.61 $2.31 9.79
2006-12-31 19.84 $2.13 9.32
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $38.988B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.809B 26.28
Medtronic (MDT) Ireland $114.856B 16.79
Stryker (SYK) United States $69.039B 24.64
Boston Scientific (BSX) United States $49.279B 23.63
Zimmer Biomet Holdings (ZBH) United States $25.460B 16.29
Smith & Nephew SNATS (SNN) United Kingdom $16.746B 0.00
Canopy Growth (CGC) Canada $16.646B 0.00
ResMed (RMD) United States $14.578B 27.64
Aurora Cannabis (ACB) Canada $9.230B 65.07
Bio-Rad Laboratories (BIO) United States $8.754B 50.22
Perrigo (PRGO) Ireland $6.685B 10.84
Hill-Rom Holdings (HRC) United States $6.417B 19.85
Insulet (PODD) United States $4.971B 1666.40
GW Pharmaceuticals (GWPH) United Kingdom $4.857B 0.00
ICU Medical (ICUI) United States $4.694B 29.07
Haemonetics (HAE) United States $4.319B 38.31
Hutchison China MediTech (HCM) China $3.951B 0.00
Agios Pharmaceuticals (AGIO) United States $3.335B 0.00
NuVasive (NUVA) United States $3.048B 26.48
Neogen (NEOG) United States $3.014B 49.01
Quidel (QDEL) United States $2.477B 22.16
National Vision Holdings (EYE) United States $2.284B 44.94
Aphria (APHA) $1.955B 0.00
HEXO (HEXO) $1.502B 0.00
Phibro Animal Health (PAHC) United States $1.342B 19.28
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.222B 877.50
AtriCure (ATRC) United States $1.081B 0.00
Lantheus Holdings (LNTH) United States $0.962B 26.00
Omeros (OMER) United States $0.930B 0.00
PetIQ (PETQ) United States $0.874B 25.02
Cerus (CERS) United States $0.826B 0.00
MacroGenics (MGNX) United States $0.805B 0.00
NanoString Technologies (NSTG) United States $0.759B 0.00
Evolus (EOLS) United States $0.721B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.720B 24.51
TG Therapeutics (TGTX) United States $0.706B 0.00
OraSure Technologies (OSUR) United States $0.596B 25.95
Surmodics (SRDX) United States $0.585B 85.02
LeMaitre Vascular (LMAT) United States $0.554B 26.32
Meridian Bioscience (VIVO) United States $0.551B 16.42
Quanterix (QTRX) United States $0.500B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.344B 0.00
Insys Therapeutics (INSY) United States $0.321B 0.00
Utah Medical Products (UTMD) United States $0.319B 20.75
BioLife Solutions (BLFS) United States $0.308B 127.08
Vapotherm (VAPO) United States $0.283B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.223B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.175B 18.69
Bovie Medical (APYX) United States $0.149B 0.00
Chimerix (CMRX) United States $0.129B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.123B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
United-Guardian (UG) United States $0.088B 20.27
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 12.64